pidotimod has been researched along with Airflow Obstruction, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jafrey, SZ; Karadkhele, A; Mahashur, A; Muchhala, S; Rathod, R; Suvarna, V; Vora, A; Waghray, P | 1 |
| Canonica, GW; Feleszko, W; Kalyuzhin, O; Krenke, R; Rossi, GA; Van Gerven, L | 1 |
1 review(s) available for pidotimod and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Immunoactive preparations and regulatory responses in the respiratory tract: potential for clinical application in chronic inflammatory airway diseases.
Topics: Asthma; Cell Extracts; Chronic Disease; Humans; Immunization; Immunologic Factors; Immunomodulation; Inflammation; Probiotics; Pulmonary Disease, Chronic Obstructive; Pyrrolidonecarboxylic Acid; Respiratory System; Respiratory Tract Diseases; Rhinitis; Sinusitis; Thiazolidines | 2020 |
1 other study(ies) available for pidotimod and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Expert Opinion on Usage of Pidotimod in Adult Patients with Chronic Obstructive Pulmonary Disease: An Indian Perspective.
Topics: Adult; COVID-19; Expert Testimony; Humans; Pulmonary Disease, Chronic Obstructive; Pyrrolidonecarboxylic Acid; SARS-CoV-2; Thiazolidines | 2021 |